APOE E2 Reference Standard
CBPA0078
询 价
索取COA
产品描述
产品数据库
| Introduction | |
| Format | Genomic DNA |
| Description | APOE include Lipoprotein Glomerulopathy and Hyperlipoproteinemia, Type Iii. Among its related pathways are Neuroscience and Lipoprotein metabolism. Gene Ontology (GO) annotations related to this gene include protein homodimerization activity and signaling receptor binding. |
| Technical Data | |
| Gene | APOE |
| APOE E2 | AA Change：p.Cys130Arg |
| DNA Change：NM 000041.4:c.388T>C | |
| Chr position (GRCh37)：NC_000019.9:g.45411941T>C | |
| Allelic Frequency：0% | |
| Zygosity：Wild Type | |
| APOE E2 | AA Change：p.Arg176Cys |
| DNA Change：NM 000041.2:c.526C>T | |
| Chr position (GRCh37)：NC000019.9:g.45412079C>T | |
| Allelic Frequency：50% | |
| Zygosity：Heterozygous | |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
Figure 1. APOE (c.388T>C) Figure 2. APOE (c.526C>T) |
| Storage | 2-8°C |
| Expiry | 36 months from the date of manufacture |
